Cathay Health — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Kojin TherapeuticsinJun 2021
BiotechBoston, US
Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)in
BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)Thomas J. Cahill(Director)
Co-investors5AM VenturesNewpath PartnersPolaris Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.